COMMENT

Covid-19 Omicron boosters will reinvigorate injectables manufacturing

Implementation of electronic health records will improve the quality of care

Despite benefits, long-acting injectables remain underutilised for schizophrenia

Coherus’ Cimerli bags approval for DME with year-long interchangeability exclusivity

UK health data collaboration paves the way to study Long Covid symptoms

Digital health

Tapping into pharma’s growing opportunities in digital health

Gérard Klop and Marcos Gallego Llorente of Vintura, explore how companies can grow their sphere of influence in the healthcare ecosystem using digital health

insight

Europe reports the highest prevalence of chronic cough

comment

Could vaccine hesitancy impact hearing disorders?

Covid-19 Omicron boosters will reinvigorate injectables manufacturing

Implementation of electronic health records will improve the quality of care

Despite benefits, long-acting injectables remain underutilised for schizophrenia

Coherus’ Cimerli bags approval for DME with year-long interchangeability exclusivity

UK health data collaboration paves the way to study Long Covid symptoms

08/22/2022 11:02:53
  • Home | Technology transformation
  • In this issue
  • Contents
  • SHL Medical Company Insight
  • SHL Medical
  • Datwyler Company Insight
  • Datwyler
  • CSafe Global
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Mimotopes Company Insight
  • Mimotopes
  • Comment
  • Tapping into pharma’s growing opportunities in digital health
  • Covid-19 Omicron boosters will reinvigorate injectables manufacturing
  • Implementation of electronic health records will improve the quality of care
  • Despite benefits, long-acting injectables remain underutilised for schizophrenia
  • FDA approves Coherus’ Cimerli for DME, with year-long interchangeability exclusivity
  • UK health data collaboration paves the way to study Long Covid symptoms
  • Molnar-Institute Company Insight
  • Molnar-Institute
  • In Depth
  • A makeover for NICE: a new look for HTAs in the UK
  • No drugs for prions: investigating new approaches to alleviate therapeutic scarc
  • Getting smart with digital pills
  • Do generics producers have what it takes to tackle complex and specialty drugs?
  • Decentralised paediatric clinical trials trending up but study execution critica
  • CMO Moves: Regulatory catalysts for drug manufacturing—August
  • Biolife Solutions
  • In Data
  • Healthtech deals decreased significantly in the pharma industry in H1 2022
  • North America is seeing a hiring boom in pharmaceutical industry machine learnin
  • Artificial intelligence mentions decrease in pharma filings in Q2 of 2022
  • Digital media hiring levels in the pharmaceutical industry rose in June 2022
  • Events
  • Next issue